4.6 Article

Endovascular thrombectomy or bridging therapy in minor ischemic stroke with large vessel occlusion

Journal

THROMBOSIS RESEARCH
Volume 219, Issue -, Pages 150-154

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2022.09.020

Keywords

Endovascular thrombectomy; Intravenous thrombolysis; Minor ischemic stroke; Large vessel occlusion

Funding

  1. National Natural Sci-ence Foundation of China
  2. Science Foundation for Post Doctorate Research of the Beijing
  3. China Postdoctoral Science Foundation
  4. [61971011]
  5. [11972049]
  6. [2020-ZZ-005]
  7. [2019M660921]
  8. [2020T130436]

Ask authors/readers for more resources

This study evaluated the efficacy of direct endovascular thrombectomy (EVT) compared to bridging therapy in patients with minor acute ischemic stroke due to large vessel occlusions (AIS-LVO). The results showed that direct EVT was comparable to bridging therapy in terms of the three-month prognosis.
Background: Whether direct endovascular thrombectomy (EVT) is non-inferior to bridging therapy (intravenous thrombolysis [IVT] followed by EVT) in minor acute ischemic stroke due to large vessel occlusions (AIS-LVO) is not clear. Therefore, this study aimed to assess whether direct EVT is non-inferior to bridging therapy in minor AIS-LVO.Methods: 903 patients with acute ischemic stroke due to large vessel occlusion and National Institutes of Health Stroke Scale (NIHSS) score <6 receiving EVT treatment were enrolled at Bigdata Observatory Platform for Stroke of China in China from January 1, 2019, to December 31, 2020, with final follow-up on March 31, 2021. The primary efficacy endpoint was a favorable outcome defined as a modified Rankin Scale score of 0 to 2 at three months. In addition, there were three prespecified secondary efficacy endpoints, including symptomatic intra-cerebral hemorrhage (ICH), in-hospital mortality, and mortality by month 3.Results: A total of 662 patients treated with direct EVT (age 65.9 +/- 10.5 years, 71.5 % male, NIHSS score 2.4 [standard deviation {SD}. 1.8]) were compared to 241 bridging-treated patients (age 65.7 +/- 10.8, 75.9 % fe-male, NIHSS score 2.5 [1.8]). The rate of symptomatic ICH in the EVT group was lower than in the bridging group (4.2 % vs. 8.3 %; P = 0.02). The in-hospital mortality was not different between the two groups (EVT vs. bridging group: adjusted hazard ratio {HR}, 0.9 [95 % confidence interval {CI}, 0.5 to 1.9]; P = 0.93). There was no significant difference in 3-month poor functional outcome rate (EVT vs. bridging group: 17.1 % vs. 16.2 % [absolute difference, 0.9 % {95 % CI,-0.8 % to 2.4 %}, P = 0.75; adjusted hazard ratio {HR}, 1.0 {95 % CI, 0.6 to 1.7}, P = 0.83]) and mortality rate (13.0 % vs. 11.2 % [absolute difference, 1.5 % {95 % CI,-3.9 % to 6.8 %}, P = 0.47; adjusted HR, 1.1 {95 % CI, 0.8 to 1.9}, P = 0.55]) between those two groups.Conclusion: Among patients with minor AIS-LVO, direct EVT, compared with bridging therapy, met the pre -specified statistical threshold for noninferiority for the 3-month prognosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available